These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10968478)

  • 1. Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure.
    Al-Mutair A; Bahabri S; Al-Mayouf S; Al-Ashwal A
    J Pediatr Endocrinol Metab; 2000; 13(7):899-905. PubMed ID: 10968478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis.
    Simon D; Touati G; Prieur AM; Ruiz JC; Czernichow P
    Acta Paediatr Suppl; 1999 Feb; 88(428):100-5. PubMed ID: 10102064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition.
    Touati G; Prieur AM; Ruiz JC; Noel M; Czernichow P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):403-9. PubMed ID: 9467548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of growth failure in juvenile chronic arthritis.
    Simon D; Lucidarme N; Prieur AM; Ruiz JC; Czernichow P
    Horm Res; 2002; 58 Suppl 1():28-32. PubMed ID: 12373011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone.
    Bechtold S; Ripperger P; Mühlbayer D; Truckenbrodt H; Häfner R; Butenandt O; Schwarz HP
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5737-44. PubMed ID: 11739431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation in non-steroid treated juvenile rheumatoid arthritis.
    Polito C; Strano CG; Olivieri AN; Alessio M; Iammarrone CS; Todisco N; Papale MR
    Scand J Rheumatol; 1997; 26(2):99-103. PubMed ID: 9137323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study.
    Simon D; Prieur AM; Quartier P; Charles Ruiz J; Czernichow P
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2567-73. PubMed ID: 17488793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.
    Frittoli RB; Longhi BS; Silva AM; Filho AAB; Monteiro MÂRG; Appenzeller S
    Rev Bras Reumatol Engl Ed; 2017; 57(2):100-106. PubMed ID: 28343613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
    Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
    Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone.
    Bechtold S; Ripperger P; Dalla Pozza R; Roth J; Häfner R; Michels H; Schwarz HP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):178-85. PubMed ID: 19880788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
    Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.